Back

Analysis of risk factors for prognostically unfavorable MI features as determined by cardiac MRI with contrast enhancement

6 May 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: ePoster session Epidemiology, Prognosis, Outcome EACVI Premium Access EuroCMR 2021

About the speaker

Photo
Doctor Terenicheva Mariya

Russian Cardiology Research and Production Complex, Moscow (Russian Federation)

100 More presentations in this session

Presentation thumbnail
Presence of dysfunction and myocardial remodeling in patients with premature ventricular complex-induced cardiomyopathy - a cardiovascular MR study
Ms N. Kirchgaessner (Kaiserslautern, DE)
Abstract Slides
Presentation thumbnail
RV function by cardiac magnetic resonance and its relationship with neutrophil/lymphocyte ratio in patients with acute inferior STEMI undergoing PPCI
Doctor S. Taha (Assiut, EG)
Abstract Slides
Presentation thumbnail
Cardiac MRI viability study and its role in revascularization- Excerpts from a tertiary care cardiac centre
Doctor A. Ruia (Chennai, IN)
Abstract Slides
Presentation thumbnail
Liver magnetic resonance relaxometry can provide useful markers for the assessment of right heart failure in dilated cardiomyopathy
Doctor P. Rafouli-Stergiou (Leuven, BE)
Abstract Slides
Presentation thumbnail
CMR derived ventricular arterial coupling in hypertrophic cardiomyopathy
Doctor A. Kharabish (Liverpool, GB)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

EuroCMR 2021

6 May 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical factors associated with microvascular obstruction in early presenters of ST-segment elevation myocardial infarction
28 August 2020
thumbnail
Congress Presentation
The role of NT-proBNP in predicting ventricular arrhythmias in young and middle-aged patients with acute coronary syndrome with ST segment elevation on background of diabetes mellitus and hypertension
20 May 2023
thumbnail
Congress Presentation
T1-mapping inversion times of the infarcted myocardium and long term cardiovascular outcomes in St-elevation myocardial infarction.
20 March 2026
thumbnail
Congress Presentation
Hematological risk factors in myocardial infarction: a comprehensive analysis from STRONG-MI
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources